New J. Chem., 2015, 39, 7309--7321.pdf (original) (raw)

Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics, 2018

Slow-Onset Inhibition of 2-trans-Enoyl-ACP (CoA) Reductase from Mycobacterium tuberculosis by an Inorganic Complex

Current Pharmaceutical Design, 2006

Design, synthesis, molecular docking and 3D-QSAR studies of potent inhibitors of enoyl-acyl carrier protein reductase as potential antimycobacterial agents

Uttam More

View PDFchevron_right

Novel Hybrid 1,2,4- and 1,2,3-Triazoles Targeting Mycobacterium Tuberculosis Enoyl Acyl Carrier Protein Reductase (InhA): Design, Synthesis, and Molecular Docking

Mariusz Jaremko

International Journal of Molecular Sciences, 2022

View PDFchevron_right

Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl- ACP(CoA) reductase enzyme OPEN

Osmar Norberto de Souza, Ivani Pauli

View PDFchevron_right

Functional, thermodynamics, structural and biological studies of in silico-identified inhibitors of Mycobacterium tuberculosis enoyl-ACP(CoA) reductase enzyme

Guilherme Petersen

Scientific reports, 2017

View PDFchevron_right

Curcumin Versus Curcumin-Iron Complex Docking in Tuberculosis Targets: A Insights on Synthesis & Molecular Docking Study

Texila International Journal

Texila International Journal of Public Health, 2024

View PDFchevron_right

Inorg. Chem. Front., 2015,.pdf

Chittaranjan Sinha

View PDFchevron_right

EPR interpretation, magnetism and biological study of a Cu(II) dinuclear complex assisted by a schiff base precursor

Kuheli Das

Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry, 2016

View PDFchevron_right

IDENTIFICATION OF ETHR INHIBITOR TARGETING MYCOBACTERIUM TUBERCULOSIS: AN INSIGHT FROM MOLECULAR DOCKING STUDY

Asian Journal of Pharmaceutical and Clinical Research Journal

Asian Journal of Pharmaceutical and Clinical Research Journal, 2022

View PDFchevron_right

Docking studies on novel alkaloid tryptanthrin and its analogues against enoyl-acyl carrier protein reductase (InhA) of Mycobacterium tuberculosis

Tarakanta Jana

Indian journal of biochemistry & biophysics, 2012

View PDFchevron_right

Research of new anti-tuberculosis agents by molecular docking's method

Abderrahmane Bensegueni

Journal of Computational Methods in Molecular Design, 2016

View PDFchevron_right

Inhibition of the Mycobacterium tuberculosis enoyl acyl carrier protein reductase InhA by arylamides

Paul Ortiz de Montellano

Bioorganic & Medicinal Chemistry, 2007

View PDFchevron_right

Computational binding mechanism of Mycobacterium tuberculosis UDP-NAG enolpyruvyl transferase (MurA) with inhibitors fosfomycin, cyclic disulfide analog RWJ-3981, pyrazolopyrimidine analog RWJ-110192, purine analog RWJ-140998, 5-sulfonoxy-anthranilic aci

Rajasekhar Chikati

2009

View PDFchevron_right

In silico Approach to Identify Potent Bioactive Compounds as Inhibitors against the Enoyl-acyl Carrier Protein (acp) Reductase Enzyme of Mycobacterium tuberculosis

Diptendu Sarkar

Biointerface Research in Applied Chemistry, 2021

View PDFchevron_right

Studies of some metal ions complexes and her antimicrobial activity by DFT and molecular Docking

said Ghalem

2015

View PDFchevron_right

An inorganic complex that inhibits Mycobacterium tuberculosis enoyl reductase as a prototype of a new class of chemotherapeutic agents to treat tuberculosis

Luiz Basso

Journal of the Brazilian Chemical Society, 2010

View PDFchevron_right

Crystal structures of Mycobacterium tuberculosis GlgE and complexes with non-covalent inhibitors

Steven Sucheck, Sri Kumar Veleti

Scientific reports, 2015

View PDFchevron_right

Pyrrolidine Carboxamides as a Novel Class of Inhibitors of Enoyl Acyl Carrier Protein Reductase from Mycobacterium tuberculosis

Robert Stroud

Journal of Medicinal Chemistry, 2006

View PDFchevron_right

Effects of changing ions on the crystal design, non-covalent interactions, antimicrobial activity, and molecular docking of Cu(II) complexes with a pyridoxal-hydrazone ligand

Claudia Gatto

Frontiers in chemistry, 2024

View PDFchevron_right

Molecular Docking, DFT, and Antibacterial Activity Study of a Newly Synthesized Mixed Ligand Complex of Co(II), 1,10-Phenanthroline, Adenine and Acetamide

Atakilt Abebe

Chemistry Africa, 2023

View PDFchevron_right

Synthesis, structural, spectral and antimicrobial activity studies of copper-nalidixic acid complex with 1,10-phenanthroline: DFT and molecular docking

Filiz Öztürk

Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 2020

View PDFchevron_right

Designing and Screening of Potent Inhibitor Against Inha Reductase of Mycobacterium Tuberculosis: A Computational Approach

Manabendra Dutta Choudhury

Asian Journal of Pharmaceutical and Clinical Research, 2014

View PDFchevron_right

Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis

Rosanna Filosa

Bioorganic & Medicinal Chemistry, 2007

View PDFchevron_right

An analysis of docking study on tuberculosis inhibitors

Manoj Giri

International Journal, 2010

View PDFchevron_right

Docking study on Mycobacterium tuberculosis receptors AccD5 and PKS18 with selected phytochemicals

Dr Anchana Devi

IOSR Journal of Pharmacy and Biological Sciences, 2012

View PDFchevron_right

Docking Studies of N-alkylated Indole Derivatives with Mycobacterium Enoyl Acyl Carrier Protein Reductase (Inh A) as Potent Antitubercular Agents

Shivam Joshi

Oriental Journal Of Chemistry

View PDFchevron_right

New J. Chem., 2015, 39, 7309--7321.pdf (original) (raw)

Related papers